Kevin Holcomb, M.D.

Gynecologic Oncology


Fruchter R, Maiman M, Arrastia CD, Matthews R, Gates EJ, Holcomb K. Is HIV Infection a Risk Factor for Advanced Cervical Cancer? J Acquir Immune Defic Syndr Hum Retrovirol 1998 Jul 1;18(3):241-245  

Holcomb K, Abulafia O, Matthews RP, Gabbur N, Lee YC, Buhl A. The effect of pretreatment staging laparotomy on survival in locally advanced cervical carcinoma. Eur J Gynecol Oncol 1999;20(2):90-93 

Holcomb K, Matthews RP, Abulafia O, Chapman J, Lee YC, Buhl A. The significance of ASCUS in HIV-positive women. Gynecol Oncol 1999;75:118-121 

Holcomb K, Matthews RP, Abulafia O, Chapman J, Lee YC, Buhl A. The efficacy of cervical conization in the treatment of cervical intraepithelial neoplasia in HIV-positive women. Gynecol Oncol 1999;74:428-431

Abulafia O, Ruiz J, Holcomb K, Dimaio T, Matthews R, Lee YC. Angiogenesis in Stage I invasive and low malignant potential epithelial ovarian carcinoma. Obstet Gynecol 2000 Apr 1;95(4):548-552. 

Holcomb K, DiMaio TM, Nicastri AD, Matthews RP, Lee YC, Buhl A. Cone biopsy and pathologic findings at radical hysterectomy in stage I cervical carcinoma. Obstet Gynecol 2001 Nov;98(5 Pt 1):779-82 

Holcomb K., Delatorre R, Pedemonte B, McLeod C, Anderson L, Chambers JT. E-cadherin expression in endometrioid, papillary serous, and clear cell carcinoma of the endometrium.  Obstet Gynecol 2002 Dec;100(6):1290-95

Holcomb K, Gabbur N, Tucker T, Matthews R, Lee Y, Abulafia O. 60Cobalt versus linear accelerator in the treatment of locally advanced cervix carcinoma: A comparison of survival and recurrence patterns. Eur J Gynaecol Oncol. 2001;22(1):16-9. 

Holcomb K, Runowicz CD. Cancer Screening. Postgraduate Obstetrics and Gynecology. 2003 Mar;23(5):1-7 

Seto-Young D, Leonardi O, Holcomb K, Park A, Salehi M, Chang P, Yih M, Rosenwaks Z, Poretsky L. Hormonally active non-transformed human ovarian cell culture from oophorectomy specimens: methods of development and characterization. Horm Res. 2005;64(5):238-47

Seto-Young D, Paliou M, Schlosser J, Avtanski D, Park A, Holcomb K, Chang P, Poretsky L.Thiazolidinedione action in the human ovary: direct effects on steroidogenesis and insulin-like growth factor binding protein-1 (IGFBP-1) production. J Clin Endocrinol Metab. 2005 Nov;90(11):6099-105

Seto-Young  D, Avtanski D, Strizhevsky M, Parikh G, Patel P, Kaplun J, Holcomb K, Rosenwaks Z, Poretsky L. Interactions among peroxisome proliferator activated receptor-gamma, insulin signaling pathways, and steroidogenic acute regulatory protein in human ovarian cells. J Clin Endocrinol Metab 92(6): 2232-9.

Huang M, Chadha MD, Musa F, Friedmann P, Kolev C, Holcomb KLymph nodes: is total number or station number a better predictor of lymph node metastasis in endometrial cancer? Gynecol Oncol. 2010 Nov;119(2):295-8

 Frey MK, Inhow SB, Heyman KP, Slomovitz BM, Kessler R, Worely MJ, Holcomb K. Minimally invasive staging of endometrial cancer is feasible and safe in elderly women. J Minim Invasive Gynecol. 2011 Mar-Apr;18(2):200-4.

Holcomb K, Vucetic Z, Miller MC, Knapp RC. Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women. Am J Obstet Gynecol. 2011 Oct;205(4):358.e1-6. 

Musa F,  Huang M, Adams B, Pirog E, Holcomb K. Mucinous histology is a risk factor for nodal metastases in endometrial cancer. Gynecol Oncol. 2012 Jun;125(3):541-5.

Musa F, Frey MK, Im HB, Chekmereva M, Ellenson LH, Holcomb K. Does the presence of adenomyosis affect and lymph-vascular invasion affect the risk of lymph node metastases in patients with endometrioid adenocarcinoma of the endometrium? Am J Obstet Gynecol. 2012 Nov;207(5):417.e1-6.

Frey MK, Biewald M, Worely MJ, Taylor J, Lin SN, Holcomb K.  Lynch syndrome awareness among medical students at a United States medical school. Curr Womens Health Rev. 2012 Aug;8(3):242-247.

Nagar H, Boothe D, Parikh A, Yondorf M, Parashar B, Gupta D, Holcomb K, Caputo T, Chao KS, Nori D, Wernicke AG. Administration of concurrent vaginal brachytherapyduring chemotherapyfor treatment of endometrial cancer. Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):665-9

 Frey MK, Bashir S, Ward NM, Hensel KJ, Caputo TA, Holcomb KM, Baergen R, Gupta D.  Role of surgical staging and adjuvant treatment in uterine serous carcinoma.  Eur. J. Gynaec. Oncol 2013;24(5):453-456.

Orfanelli T, Jeong J, Doulaveris G, Holcomb K, Witkin S. Involvement of Autophagy in Cervical, Endometrial and Ovarian Cancer. Int J Cancer 2013 Oct 7. doi: 10.1002/ijc.28524. [Epub ahead of print]

Galic V, Schiavone MB, Herzog TJ, Holcomb K, Lewin SN, Lu YS, Neugut AI, Hershman DL, Wright JD. Prognostic significance of mucinous differentiation of endometrioid adenocarcinoma of the endometrium. Cancer Invest 2013 Aug;31(7):500-4.

Back to topBack To Top